We herein report a case of primary hyperparathyroidism associated with acromegaly. Although serum parathyroid hormone ( 
Introduction
Primary hyperparathyroidism (PHPT) is characterized by hypercalcemia resulting from parathyroid hormone (PTH)-induced increases in calcium (Ca) entry into the blood from the intestine, bone and kidney. The increased Ca entry from the intestine and kidney is mediated by a PTH-induced increase in the production of 1 , 25-dihydroxyvitamin D [1, 25(OH)2D] at the proximal convoluted tubule (1) .
Growth hormone (GH) is also known to activate vitamin D metabolites from 25-hydroxyvitamin D to 1, 25(OH)2D at the site of the renal tubules (2) . In fact, GH administration is reported to cause a significant increase in serum 1, 25(OH)2D and concomitant increase in serum Ca and phosphate (Pi) (3) .
There are few reports on the combination of PHPT and acromegaly. Hypercalcemia occurs in 5-10% of acromegalic patients and usually results from parathyroid adenoma or hyperplasia, mostly associated with multiple endocrine neoplasia syndrome type 1 (4). GH is known to enhance vitamin D activation and thus lead to hypercalciuria in 80% of acromegaly cases (4) . However, the effect in such cases of GH on PTH-induced abnormalities in the Ca metabolism, particularly with regard to vitamin D activation, has not been elucidated.
We herein report a case of PHPT associated with acromegaly which presented in the form of hypercalcemia. It is suggested that the mechanism by which hypercalcemia occurred in the present case involved an increase in serum 1, 25(OH)2D levels mediated by either PTH or GH. Evidence for this is provided by the partial reduction in serum 1, 25(OH)2D levels after removal of a pituitary tumor and the final normalization of serum 1, 25(OH)2D after parathyroidectomy (PTX).
Case Report
A 66-year-old female had noticed a progressive increase in the size of her hands and feet over 20 years and disfigurement of her face, but did not subject herself to further medical examination. Although the patient was free of symptoms, On admission, the patient measured 146.1 cm in height and 54 kg in weight. The blood pressure was 132/80 mmHg and pulse regular at 74/min. The face featured a protruding chin, thick lips, and an enlarged nose and the tongue was large and thick. Palpation revealed no anterior neck swelling suggestive of thyroid or parathyroid disorder. The lung, heart, and abdomen appeared normal. The size of the hands and feet was increased. No peripheral edema was found.
Laboratory data on admission are shown in Tables 1 and  2 . The fasting plasma glucose (FPG) (7.2 mmol/l) and HbA1c (5.8%) were elevated and presented clinical signs of diabetes mellitus. The levels of growth hormone (GH) (16± 1.9 g/l) and insulin-like growth factor-1 (IGF-1) (77.29 nmol/l) and the daily urinary excretion of GH (826 ng/g Cre) were all elevated. Serum GH did not fall below 2 g/l during a 2-hour period after a 75-g oral glucose load.
Serum levels of TSH and thyroid hormone were both within the respective normal range. The levels of serum LH and FSH were elevated, but within the normal range for menopausal women. The serum level of Ca (2.84±0.05 mmol/l) was elevated and serum Pi was 0.97±0.04 mmol/l. Daily urinary excretion of Ca was elevated to 9.76±0.20 mmol/day. Urinary excretion of Pi (2.17±0.05 mol/day) was within the normal range. Serum PTH (140.5±3.0 ng/l) and 1, 25(OH)2D (283.4±13.3 pmol/l) measured respectively by intact PTH assay and radioimmunoassay [1, 25(OH)2D RIA kit TFB] were both above the normal upper limit. Bone turnover was enhanced as evidenced by a significant increase in biochemical markers of bone metabolism including serum bone alkaline phosphatase (BAP) (81.6 IU/l), osteocalcin (3.42 nmol/l), urinary excretion of hydroxyproline (766 mol/l), deoxypyridinoline (DPD) (16.2 pM/ M Cre), and Values of clinical parameters are shown as the means±SD. The differences of clinical parameters between two groups (before TSS vs After TSS, After TSS vs After PTX) were analyzed by Student's t test. After the TSS, serum GH was normalized, while serum 1, 25(OH)2D also decreased, but remained above the normal upper limit. With the decrease in the concentration of 1, 25(OH)2D, the serum level of Ca decreased and the level of PTH increased significantly. Through PTX, serum levels of PTH, Ca, Pi, and 1, 25(OH)2D and urinary excretion of Pi were all restored to normal levels. *difference between two groups was statistically significant, p<0.05.
pyridinoline (PYD) (89.4 pM/ M Cre).
Computed tomography (CT) of the neck disclosed a mass adjacent to the lower pole of the right lobe of the thyroid gland while Tc-99m sestamibi scintigraphy showed a hot spot in the lower right portion of the thyroid gland, both indicating the presence of parathyroid adenoma (Figure 1 ). CT and magnetic resonance imaging (MRI) of the pituitary gland revealed a pituitary adenoma (Figure 2 ). Given the GH excess and the presence of a pituitary adenoma, a GHsecreting pituitary adenoma was diagnosed. The levels of pancreatic hormones such as insulin, glucagon, and gastrin were all within the normal range and abdominal CT did not show pancreatic tumor. Menin-gene abnormality was not investigated.
As a first step, on December 18, the GH-producing pituitary adenoma was resected using the transsphenoidal approach. This resulted in the normalization of the serum concentration of GH and IGF-1, and a decrease in serum 1, 25(OH)2D to 209.6±6.1 pmol/l, still however above the normal upper limit. With the decrease in the concentration of 1, 25(OH)2D, the serum level of Ca decreased from 2.84± 0.05 to 2.64±0.02 mmol/l (p=0.0131, analyzed by student's t test) and PTH levels were significantly increased from 140.5±3.0 to 157.0±6.0 (p=0.0108, analyzed by student's t test). The increase in the serum level of PTH led to increased daily urinary Pi excretion (2.60±0.20 mol/day) (Table 3) .
Secondly, on February 12, the lower right gland of the parathyroid was resected. Through PTX, serum levels of PTH (34±10 ng/l), serum Ca (2.17±0.07 mmol/l), and serum Pi (1.16±0.06 mmol/l) and urinary excretion of Pi (1.50±0. 
